Gradient Investments LLC Bristol Myers Squibb CO Transaction History

Gradient Investments LLC

$3.79 Billion
Q3 2024

A detailed history of Gradient Investments LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Gradient Investments LLC holds 5,921 shares of BMY stock, worth $344,779. This represents 0.01% of its overall portfolio holdings.

Number of Shares

5,921

Previous 5,393 9.79%

Holding current value

$344,779

Previous $223,000 37.22%

% of portfolio

0.01%

Previous 0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	BUY	$39.66 - $51.75 $20,940 - $27,324	528 Added 9.79%	5,921 $306,000
Q2 2024 Jul 18, 2024	BUY	$40.25 - $52.99 $18,072 - $23,792	449 Added 9.08%	5,393 $223,000
Q1 2024 Apr 23, 2024	SELL	$47.98 - $54.4 $265,617 - $301,158	-5,536 Reduced 52.82%	4,944 $268,000
Q4 2023 Jan 18, 2024	SELL	$48.48 - $57.85 $7.1 Million - $8.48 Million	-146,536 Reduced 93.33%	10,480 $537,000
Q3 2023 Oct 27, 2023	SELL	$57.89 - $64.73 $12.4 Million - $13.9 Million	-214,571 Reduced 57.74%	157,016 $9.11 Million
Q2 2023 Jul 11, 2023	BUY	$63.71 - $70.74 $2.92 Million - $3.24 Million	45,856 Added 14.08%	371,587 $23.8 Million
Q1 2023 Apr 17, 2023	BUY	$65.71 - $74.53 $3.53 Million - $4 Million	53,679 Added 19.73%	325,731 $22.6 Million
Q4 2022 Jan 10, 2023	BUY	$68.48 - $81.09 $606,595 - $718,295	8,858 Added 3.37%	272,052 $0
Q3 2022 Oct 14, 2022	BUY	$0.13 - $76.84 $2,795 - $1.65 Million	21,504 Added 8.9%	263,194 $18.7 Million
Q2 2022 Jul 11, 2022	SELL	$72.62 - $79.98 $3.4 Million - $3.75 Million	-46,860 Reduced 16.24%	241,690 $18.6 Million
Q1 2022 May 26, 2022	SELL	$61.48 - $73.72 $2.79 Million - $3.34 Million	-45,328 Reduced 13.58%	288,550 $21.1 Million
Q4 2021 Jan 12, 2022	BUY	$53.63 - $62.52 $826,652 - $963,683	15,414 Added 4.84%	333,878 $20.8 Million
Q3 2021 Oct 18, 2021	BUY	$59.17 - $69.31 $3.95 Million - $4.62 Million	66,681 Added 26.48%	318,464 $18.8 Million
Q2 2021 Jul 12, 2021	BUY	$61.91 - $67.42 $472,001 - $514,010	7,624 Added 3.12%	251,783 $16.8 Million
Q1 2021 Apr 21, 2021	BUY	$59.34 - $66.74 $1.9 Million - $2.14 Million	32,012 Added 15.09%	244,159 $15.4 Million
Q4 2020 Jan 08, 2021	SELL	$57.74 - $65.43 $134,072 - $151,928	-2,322 Reduced 1.08%	212,147 $12.8 Million
Q3 2020 Oct 06, 2020	BUY	$57.43 - $63.64 $1.11 Million - $1.23 Million	19,358 Added 9.92%	214,469 $12.9 Million
Q2 2020 Jul 10, 2020	SELL	$54.82 - $64.09 $471,123 - $550,789	-8,594 Reduced 4.22%	195,111 $11.5 Million
Q1 2020 Apr 07, 2020	BUY	$46.4 - $67.43 $225,596 - $327,844	4,862 Added 2.45%	203,705 $11.4 Million
Q4 2019 Jan 15, 2020	SELL	$49.21 - $64.19 $1.12 Million - $1.46 Million	-22,821 Reduced 10.3%	198,843 $12.8 Million
Q3 2019 Oct 10, 2019	BUY	$42.77 - $50.71 $140,242 - $166,278	3,279 Added 1.5%	221,664 $11.2 Million
Q2 2019 Jul 16, 2019	BUY	$44.62 - $49.34 $2.67 Million - $2.95 Million	59,832 Added 37.74%	218,385 $9.9 Million
Q1 2019 Apr 11, 2019	SELL	$45.12 - $53.8 $992,459 - $1.18 Million	-21,996 Reduced 12.18%	158,553 $7.57 Million
Q4 2018 Jan 18, 2019	BUY	$48.76 - $63.23 $8.37 Million - $10.9 Million	171,724 Added 1945.88%	180,549 $9.39 Million
Q3 2018 Oct 11, 2018	BUY	$55.19 - $62.25 $15,729 - $17,741	285 Added 3.34%	8,825 $548,000
Q2 2018 Aug 09, 2018	SELL	$50.53 - $62.98 $454 - $566	-9 Reduced 0.11%	8,540 $473,000
Q1 2018 Apr 11, 2018	BUY	$59.92 - $68.98 $17,077 - $19,659	285 Added 3.45%	8,549 $541,000
Q4 2017 Feb 07, 2018	SELL	$59.94 - $65.35 $2,877 - $3,136	-48 Reduced 0.58%	8,264 $506,000
Q3 2017 Oct 16, 2017	BUY	$55.23 - $63.74 $459,071 - $529,806	8,312	8,312 $530,000

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $124B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gradient Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gradient Investments LLC with notifications on news.

Account

Gradient Investments LLC Bristol Myers Squibb CO Transaction History